Skip to content

Computerized Cognitive Training for MCI

A Randomized Control Trial on Computerized Cognitive Training for Individuals With Mild Cognitive Impairment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03232047
Enrollment
120
Registered
2017-07-27
Start date
2017-08-01
Completion date
2019-12-31
Last updated
2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

Computerized, Executive function, memory, cognitive training, Mild Cognitive Impairment

Brief summary

The objective of the study is to evaluate whether memory training combined with executive training could lead to improved cognitive and noncognitive performance in patients with MCI. Furthermore, we will explore the neural correlates underlying the changed performances.

Detailed description

Introduction: Mild cognitive impairment (MCI) is a clinical condition characterized of a reduction in memory and/or other cognitive processes that are insufficiently severe to be diagnosed as dementia, but are more pronounced than the cognitive decline associated with normal aging. The prevalence of MCI ranges from 3% to 19% in adults older than 65 years; some of these individuals seem to remain stable or return to normal over time, but more than half progress to dementia within 5 years. Thus, MCI represents a critical window of opportunity for intervening and altering the trajectory of both cognitive decline and loss of functional independence in older adults. Cognitive function apart from memory such as executive function is also impaired in patients with MCI. However, no study has yet placed sufficient emphasis on the training of executive function. Objectives: The objective of the study is to evaluate whether memory training combined with executive training could lead to improved cognitive and noncognitive performance in patients with MCI. Furthermore, we will explore the neural correlates underlying the changed performances. Patients and Methods: The proposed study is a single blinded, randomized and controlled trial that will include 120 elderly patients with MCI from the memory clinic. The groups will be randomized to either intervention or waiting-list group. The intervention is computerized combined memory and executive function training performed for 60 minutes x 4 times/week over 26 weeks. A neuropsychological assessment will be administered at baseline and week 4, 12 and 26 after the intervention. The structural and functional MRI, EEG and NIRS will be performed at baseline and week 26 after intervention for a sub-study on the effect of cognitive training on brain structure and function.

Interventions

DEVICECombined executive function and memory training

Computerized combined executive function and memory training

Sponsors

Peking University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

1. An objective cognition impairment (a Montreal Cognitive Assessment (MoCA) score \< 26) 2. Preserved general cognitive function( an mini-mental state examination (MMSE) score of \> 24) 3. Clinical Dementia Rating (CDR) = 0.5 4. Hamilton Depression Scale (HAMD) score of \< 12 5. Intact activities of daily living (ADL score of \<=26) 6. Schooling education \> = 5 years) 7. Not meeting the diagnosis of dementia (according to the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) Probable Alzheimer's Criteria

Exclusion criteria

1. Serious visual or hearing impairment; 2. Hachinski Ischemia Scale (HIS) \>= 4; 3. Subjects with Axis I disorders listed in the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), any other neurological disorders that could affect cognitive function; 4. currently on titration of medications with cognitive enhancers or antidepressants; 5. having any physical condition that could preclude regular attendance and full intervention-program participation

Design outcomes

Primary

MeasureTime frameDescription
Composite working memory z scoreChange from baseline composite working memory z score at week 26composite score of digit span and spatial span

Secondary

MeasureTime frameDescription
Self evaluated memory abilityChange from baseline self evaluated memory ability at week 26Score on the questionnaire probes worries about memory (MMQ-contentment).
Brain Functional Imagingchange from baseline functional connectivity at week 26Brain function measured with MRI.
Electrical activity of the brainchange from baseline electrical brain activity at week 26Brain activity measured with electroencephalography (EEG).
Brain structural imagingchange from baseline cortical thickness at week 26cortical thickness measured with MRI
cognitive test package (CTP)Changes from baseline composite CTP score at week 26composite score of episodic memory, speed processing, executive function, attention, language and social cognition
MoodChange from baseline composite mood score at week 26composite score of mood status
BDNF levelchange from baseline serum BDNF level at week 26Serum Brain-derived neurotrophic factor (BDNF) level
Composite of overall cognition z scoresChanges from baseline composite overall cognition z score at week 26Score on Montreal Cognitive Assessment (MoCA) and Mini-mental State Examination (MMSE).
cerebral blood flowchange from baseline cerebral blood flow at week 26Cerebral blood flow measured with Near-infrared spectroscopy (NIRS).

Countries

China

Contacts

Primary ContactHuali Wang, MD
huali_wang@bjmu.edu.cn+86-10-82801983
Backup ContactHaifeng Zhang, MS

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026